Omzo review

Omzo for moms: our verdict

The homepage says $179. The terms and conditions — where this seller keeps its real price list, six itemized packages of it — say that from the second month on it is $299. They say something else too: that $179 was the previous price and $199 is the current one, which is an increase written with the grammar of a discount. As for the $279 the homepage puts on tirzepatide: it is not in that list. In any position. The advertised starting price is $199, but the regular rate settles nearer $299/mo — so read the headline as an intro offer, not as the monthly cost.

We looked at Omzo the way moms actually have to: not just the monthly cost, but the right timing around pregnancy and nursing and honest, clear pricing from the start — the parts a generic weight-loss review skips.

What Omzo actually costs

• Compounded semaglutide — Following months — the standing rate: $199 to start, then $299/mo
• Compounded tirzepatide — Following months — the standing rate: $349 to start, then $399/mo
• Brand-name semaglutide — Ozempic — every month: $1299/mo
• Brand-name tirzepatide — Zepbound — every month: $1399/mo

For context, the typical ongoing price on our list is around $179/mo, so Omzo sits at the pricier end.

That price covers the consult, the medication and shipping.

The medications Omzo prescribes

Omzo lists semaglutide and tirzepatide. Offering both gives a prescribing clinician options, but PCOS or a history of gestational diabetes alone does not establish which medication is right for you. It can point you toward FDA-approved brand-name medications as well as the compounded versions — approved products carry the manufacturer's own pregnancy and breastfeeding label, which is cleaner to hand to an OB-GYN.

Where it operates. Omzo lists its coverage as: All 50 states.

Where Omzo fits — and where it doesn't — for moms

A good fit if…

• you want to discuss both semaglutide and tirzepatide with your prescribing clinician.
• broad access matters to you; confirm treatment eligibility in your current state and any new state before moving.

Look elsewhere if…

• you need to discuss the right timing around pregnancy and nursing with your treating clinician before choosing. If comparing prices with CoreAge Rx, request the offer and terms separately from that clinical decision.

Trust, safety and oversight

Before choosing Omzo, confirm the dispensing pharmacy and the clinician responsible for your prescription. Public information alone does not establish the quality of care you will receive. As with any compounded GLP-1, the most useful thing moms can do is confirm which licensed pharmacy fills the prescription and what's in the formula — we explain how we score oversight in our scoring methodology.

Pregnancy and breastfeeding need separate discussions with your clinician. GLP-1 weight-loss treatment is not recommended during pregnancy. During breastfeeding, the exact drug and formulation matter: Wegovy tablets are not recommended because of the SNAC absorption ingredient. Injectable semaglutide and tirzepatide labels call for weighing benefits, risks and the limits of infant-safety data; they do not establish that treatment is safe for every nursing parent. Compounded products do not inherit FDA approval from the branded drug. Discuss your own medication and timing before starting or changing treatment.

The bottom line

Omzo is a reasonable option — weigh it on the right timing around pregnancy and nursing and honest, clear pricing from the start against the alternatives below. For moms comparing another compounded offer, CoreAge Rx describes prices and terms to confirm for the selected dose and plan.